Development and Maintenance of Thymic Epithelial Microenvironments
Development and Maintenance of Thymic Epithelial Microenvironments
批准号:
8527705
负责人:
MARK PEZZANO
金额:
$32.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-15 至 2016-07-31
关键词:
AddressAdipocytesAdultArchitectureAtrophicBiological ModelsBloodBone MarrowBone Marrow TransplantationCancer PatientCell CommunicationCell LineCell MaintenanceCell physiologyCell surfaceCellsCharacteristicsChondrocytesClinicalCoculture TechniquesDevelopmentDiseaseEngraftmentEpithelialExhibitsFluorescenceGene ExpressionGenesGenetically Engineered MouseGrowthHematological DiseaseHematopoiesisHematopoieticHematopoietic stem cellsHistonesHomeostasisHumanImmuneImmune systemIn VitroInfectionInjection of therapeutic agentIntegrinsKidneyLabelLeadLifeLocationMaintenanceMalignant - descriptorMalignant NeoplasmsMapsMesenchymalMesenchymal Stem CellsMinority-Serving InstitutionMorbidity - disease rateMouse StrainsNatural regenerationNon-MalignantNude MiceOperative Surgical ProceduresOsteoblastsPatientsPhenotypePopulationPopulation HeterogeneityProductivityPropertyProteinsPubertyPublicationsRecoveryRecruitment ActivityRelapseReporterResearchResearch PersonnelRoleSignal PathwaySignal TransductionSkinSorting - Cell MovementStem Cell FactorStem cell transplantStem cellsStructureStudentsT-Cell DevelopmentT-LymphocyteTACSTD2 geneTestingThymic TissueThymic epithelial cellThymus GlandTimeTissuesTrainingTransgenic MiceTransgenic ModelTranslationsTransplantationUnited States National Institutes of Healthadaptive immunityadult stem cellbasebonecancer therapycapsuledesignfightingfunctional lossimmune functionimprovedin vivoinhibitor/antagonistmouse modelnovelpluripotencypostnatalprematureprogenitorpublic health relevancereconstitutionresponseself-renewalstem cell populationtreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Development and maintenance of a properly functioning immune system is dependent upon a properly organized and functioning thymus. Thymic epithelial cells (TECs) make up the structure of the thymus and are responsible for the maintaining its primary functions. Bone marrow transplants can cure many forms of blood-derived cancers as well as non-malignant blood disorders. Unfortunately, particularly in adult patients, bone marrow transplants damage the thymus and in particular TECs resulting in a reduced capacity to fight infection and cancer. Stem cells in a variety of tissues have been identified by their capacity to divide very slowly, the so-called "label retaining cells" (LRCs). A
novel genetically engineered mouse model system, which allows identification and purification of viable Histone 2B-green fluorescence protein tagged stem cells and was successfully used to identify and purify skin stem cells, has been used here to purify thymic epithelial stem cells. Preliminary results show that surgical transfer of these cells under the kidney capsule results in the formation of functional thymic tissue. The aims of this study will be to: 1) further characterie the recently identified thymic epithelial stem cells with the ability to reform thymic tissue; 2) understand the signals and cell to cell interactions that control the maintenance of adult thymic stem cells; 3) test the capacity of thymic stem cells and recently developed stem cell lines to enhance the recovery of thymic function in a mouse model of bone marrow transplant. These studies will be instrumental in the design of new clinical strategies to counteract thymic involution as well as the premature thymic degeneration that occurs in response to cancer treatments and BMT. From a developmental standpoint this study will allow the PI to continue to train underserved research students, while enhancing both the scientific productivity of the lab and the impact of the publications produced, enabling a researcher at a minority serving institution to be more competitive for NIH support.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular/Molecular Basis of Development: Research Center
-
批准号:9359238
-
项目类别:
-
资助金额:$4.19万
-
财政年份:2015
-
负责人:MARK PEZZANO
-
依托单位:
Cellular/Molecular Basis of Development: Research Center
-
批准号:9359286
-
项目类别:
-
资助金额:$8.74万
-
财政年份:2015
-
负责人:MARK PEZZANO
-
依托单位:
Cellular/Molecular Basis of Development: Research Center
-
批准号:9359244
-
项目类别:
-
资助金额:$4.11万
-
财政年份:2015
-
负责人:MARK PEZZANO
-
依托单位:
Cellular/Molecular Basis of Development: Research Center
-
批准号:9359285
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2015
-
负责人:MARK PEZZANO
-
依托单位:
Cellular/Molecular Basis of Development: Research Center
-
批准号:9359283
-
项目类别:
-
资助金额:$54.19万
-
财政年份:2015
-
负责人:MARK PEZZANO
-
依托单位:
Cellular/Molecular Basis of Development: Research Center
-
批准号:9359284
-
项目类别:
-
资助金额:$3.69万
-
财政年份:2015
-
负责人:MARK PEZZANO
-
依托单位:
Development and Maintenance of Thymic Epithelial Microenvironments
-
批准号:8338776
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2012
-
负责人:MARK PEZZANO
-
依托单位:
Development and Maintenance of Thymic Epithelial Microenvironments
-
批准号:8697010
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2012
-
负责人:MARK PEZZANO
-
依托单位:
AREA IV IMMUNOLOGY
-
批准号:8357150
-
项目类别:
-
资助金额:$37.02万
-
财政年份:2011
-
负责人:MARK PEZZANO
-
依托单位:
AREA IV IMMUNOLOGY
-
批准号:7959167
-
项目类别:
-
资助金额:$36.24万
-
财政年份:2009
-
负责人:MARK PEZZANO
-
依托单位:
AREA IV IMMUNOLOGY
-
批准号:8166247
-
项目类别:
-
资助金额:$31.65万
-
财政年份:2009
-
负责人:MARK PEZZANO
-
依托单位:
Crosstalk Control of Thymic Epithelial Development
-
批准号:8091653
-
项目类别:
-
资助金额:$3.2万
-
财政年份:2008
-
负责人:MARK PEZZANO
-
依托单位:
AREA IV IMMUNOLOGY
-
批准号:7715273
-
项目类别:
-
资助金额:$50.13万
-
财政年份:2008
-
负责人:MARK PEZZANO
-
依托单位:
Crosstalk Control of Thymic Epithelial Development
-
批准号:7638658
-
项目类别:
-
资助金额:$26.95万
-
财政年份:2008
-
负责人:MARK PEZZANO
-
依托单位:
Crosstalk Control of Thymic Epithelial Development
-
批准号:7429263
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2008
-
负责人:MARK PEZZANO
-
依托单位:
Crosstalk Control of Thymic Epithelial Development
-
批准号:7877928
-
项目类别:
-
资助金额:$26.68万
-
财政年份:2008
-
负责人:MARK PEZZANO
-
依托单位:
Crosstalk Control of Thymic Epithelial Development
-
批准号:8104282
-
项目类别:
-
资助金额:$26.68万
-
财政年份:2008
-
负责人:MARK PEZZANO
-
依托单位:
AREA IV IMMUNOLOGY
-
批准号:7561534
-
项目类别:
-
资助金额:$50.44万
-
财政年份:2007
-
负责人:MARK PEZZANO
-
依托单位:
AREA IV IMMUNOLOGY
-
批准号:7336059
-
项目类别:
-
资助金额:$46.69万
-
财政年份:2006
-
负责人:MARK PEZZANO
-
依托单位:
TNC FUNCTION IN APOPTOTIC ANTIGEN DRIVEN AUTOIMMUNITY
-
批准号:7164332
-
项目类别:
-
资助金额:$10.12万
-
财政年份:2005
-
负责人:MARK PEZZANO
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: